bioAffinity Technologies, Inc. Common Stock (BIAF) Stock Price

BIAFStock

$3.73−92.71%52W

Market Cap$4.79M

P/E—

PEG Ratio—

Div yield—

Beta-1.17

BIAF Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-101.06%

Price vs S&P 500 (4W)-50.23%

VGM Score45.93

Book Value / Share (Quarterly)$0.56

P/TBV (Annual)0.81x

Indicated Dividend (Annual)$0.00

Cash Flow / Share (Quarterly)$-1.70

Price vs S&P 500 (YTD)-90.85%

Gross Margin (TTM)34.61%

Net Profit Margin (TTM)-257.33%

EPS (TTM)$-6.89

10-Day Avg Trading Volume3.80M

EPS Excl Extra (TTM)$-6.89

EPS (Annual)$-8.66

ROI (Annual)-184.15%

Gross Margin (Annual)31.40%

Cash / Share (Quarterly)$0.36

Revenue Growth QoQ (YoY)18.99%

ROA (Last FY)-136.03%

Revenue Growth TTM (YoY)-23.17%

EBITD / Share (TTM)$-3.14

Operating Margin (TTM)-209.82%

Cash Flow / Share (Annual)$-2.09

P/B Ratio1.27x

P/B Ratio (Quarterly)1.35x

Net Income / Employee (Annual)$-261,600

EV / Revenue (TTM)0.51x

Net Interest Coverage (TTM)-2.88x

ROA (TTM)-159.54%

EPS Incl Extra (Annual)$-8.66

Current Ratio (Annual)2.60x

Quick Ratio (Quarterly)1.36x

3-Month Avg Trading Volume2.65M

52-Week Price Return-92.71%

Revenue / Employee (TTM)$103,500

Tangible BV / Share (Quarterly)$0.45

P/S Ratio (Annual)0.78x

Asset Turnover (Annual)0.56x

52-Week High$80.70

EPS Excl Extra (Annual)$-8.66

26-Week Price Return-91.15%

Quick Ratio (Annual)2.51x

13-Week Price Return-64.68%

Total Debt / Equity (Annual)0.11x

Current Ratio (Quarterly)1.44x

Enterprise Value$2.99M

Asset Turnover (TTM)0.62x

Revenue / Employee (Annual)$108,100

Inventory Turnover (Annual)104.16x

Pretax Margin (Annual)-241.25%

Cash / Share (Annual)$1.43

3-Month Return Std Dev249.98%

Net Income / Employee (TTM)$-266,400

ROE (Last FY)-204.87%

Net Interest Coverage (Annual)-3.36x

EPS Basic Excl Extra (Annual)$-8.66

Receivables Turnover (TTM)9.24x

Total Debt / Equity (Quarterly)0.17x

EPS Incl Extra (TTM)$-6.89

Receivables Turnover (Annual)7.57x

ROI (TTM)-233.05%

P/S Ratio (TTM)0.81x

Revenue / Share (Annual)$3.58

Tangible BV / Share (Annual)$1.46

Price vs S&P 500 (52W)-108.24%

Year-to-Date Return-78.93%

5-Day Price Return-4.36%

EPS Normalized (Annual)$-8.66

ROA (5Y Avg)-174.96%

Net Profit Margin (Annual)-241.96%

Month-to-Date Return-43.14%

Cash Flow / Share (TTM)$-0.95

EBITD / Share (Annual)$-5.85

Operating Margin (Annual)-171.58%

LT Debt / Equity (Annual)0.01x

LT Debt / Equity (Quarterly)0.01x

EPS Basic Excl Extra (TTM)$-6.89

P/TBV (Quarterly)1.66x

P/B Ratio (Annual)0.73x

Inventory Turnover (TTM)61.08x

Pretax Margin (TTM)-257.23%

Book Value / Share (Annual)$1.62

Price vs S&P 500 (13W)-67.36%

Beta-1.17x

Revenue / Share (TTM)$1.13

ROE (TTM)-257.27%

52-Week Low$3.23

vGradeA

gGradeC

mGradeF

vgmGradeC

BIAF Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q3 2025	Nov 14, 2025	-$40.50	-$71.10	-75.56%(-$30.60)
Q2 2025	Aug 14, 2025	-$45.00	-$76.50	-70.00%(-$31.50)
Q1 2025	May 15, 2025	-$72.00	-$72.00	+0.00%(+$0.00)
Q4 2024	Mar 31, 2025	-$63.00	-$94.50	-50.00%(-$31.50)

BIAF Analyst Recommendations

Dec 2025

Jan 2026

Feb 2026

Mar 2026

2.17

Industry Peers — R&D — Physical Sciences(17)

Symbol	Value Score	Growth Score	Momentum Score	P/E Ratio (Annual)	ROE (TTM)	Revenue Growth (5Y)	Indicated Dividend Yield (Annual)	Price
BIAFbioAffinity Technologies, Inc. Common Stock	A	C	F	—	-257.3%	—	—	$3.73
IQVIQVIA Holdings Inc.	D	C	A	32.3x	21.9%	7.5%	—	$266.90
INCYIncyte Genomics Inc	C	B	B	17.8x	29.6%	14.0%	—	$113.07
MEDPMedpace Holdings, Inc. Common Stock	F	B	B	38.3x	110.2%	22.3%	—	$618.47
CRLCharles River Laboratories International, Inc.	F	D	A	—	-7.7%	6.5%	—	$300.15
ICLRIcon Plc	C	C	B	57.3x	0.8%	24.1%	—	$170.18
ABSIAbsci Corporation Common Stock	F	F	B	—	-59.2%	-10.1%	—	$8.25
OABIOmniAb, Inc. Common Stock	F	B	A	—	-16.6%	-4.3%	—	$4.59
NRCNRC Health Common Stock	D	D	B	38.4x	48.5%	0.6%	1.2%	$20.15
MXCTMaxCyte, Inc. Common Stock	C	D	B	—	-21.0%	4.8%	—	$1.30
IBACIB Acquisition Corp. Common Stock	—	D	C	15.9x	-3.7%	—	—	$10.86
ONMDOneMedNet Corp Class A Common Stock	D	A	D	—	-6.8%	—	—	$4.51
ISPCiSpecimen Inc. Common Stock	—	F	F	—	-524.4%	-25.1%	—	$0.92
BIAFWbioAffinity Technologies, Inc. Warrant	—	—	C	—	—	—	—	$0.32
IBACRIB Acquisition Corp. Right	—	D	C	15.9x	-3.7%	—	—	$0.11
NOTVInotiv, Inc. Common Stock	B	B	F	—	-74.7%	53.4%	—	$0.00
OABIWOmniAb, Inc. Warrant	—	—	B	—	—	—	—	$0.24
ONMDWOneMedNet Corp Warrant	—	—	C	—	—	—	—	$0.03

About bioAffinity Technologies, Inc. Common Stock

bioAffinity Technologies Inc develops noninvasive diagnostic tests and targeted cancer therapeutics, with a focus on early-stage cancer detection. The company's lead product, CyPath Lung, is a proprietary noninvasive test for detecting early-stage lung cancer. Its technology platform addresses a significant clinical market need for improved cancer diagnosis and treatment options.